Genetics and Life Insurance: Medical Underwriting and Social Policy

MIT Press (2004)
  Copy   BIBTEX

Abstract

Experts discuss the economic, legal, and social issues surrounding the use of genetic testing in determining eligibility for life insurance. Insurance companies routinely use an individual's medical history and family medical history in determining eligibility for life insurance; this is part of the process of medical underwriting. Insurers have also long used genetic information, often derived from family history, in underwriting. But rapid advances in gene identification and genetic testing are changing the way we look at genetic information. Should the results of genetic testing (which might identify a predisposition toward disease not related to medical history) be available to life insurance medical underwriters? Few if any life insurers currently require genetic testing, but there are no laws or regulations prohibiting its use. Genetics and Life Insurance examines the complex economic, legal, and social issues surrounding the use of genetic information in life insurance underwriting. The contributors are legal scholars, representatives of the life insurance industry (including an actuary and an insurance physician), a geneticist, a genetic counselor, a philosopher, and a consumer advocate. They explore all aspects of an issue that has only recently drawn the attention of policymakers and the public. The book opens with a report on the results of a public opinion poll on genetics and life insurance. Succeeding chapters present the insurer perspective, a discussion of the economics of risk selection in life insurance, background information on the process of underwriting, a scientific analysis of genetic risks and mortality rates, a philosophical discussion of fairness and genetic underwriting, the viewpoints of consumers and genetics counselors, a comparison of different international policy approaches to the issue, and a legal analysis of antitrust implications when insurers collaborate in setting standards for medical underwriting. In the final chapter the editor addresses various policy options, examining the pros and cons of each one and assessing their political feasibility.

Other Versions

No versions found

Links

PhilArchive

    This entry is not archived by us. If you are the author and have permission from the publisher, we recommend that you archive it. Many publishers automatically grant permission to authors to archive pre-prints. By uploading a copy of your work, you will enable us to better index it, making it easier to find.

    Upload a copy of this work     Papers currently archived: 104,957

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Life, Health, and Disability Insurance: Understanding the Relationships.Robert H. Jerry - 2007 - Journal of Law, Medicine and Ethics 35 (S2):80-89.
Can Genetic Nondiscrimination Laws Save Lives?Mark A. Rothstein - 2020 - Hastings Center Report 51 (1):6-7.
Life, Health, and Disability Insurance: Understanding the Relationships.Robert Jerry Ii - 2007 - Journal of Law, Medicine and Ethics 35 (s2):80-89.
Genetics and the British insurance industry.E. D. Cook - 1999 - Journal of Medical Ethics 25 (2):157-162.
Genetic Exceptionalism and Legislative Pragmatism.Mark A. Rothstein - 2007 - Journal of Law, Medicine and Ethics 35 (S2):59-65.

Analytics

Added to PP
2015-02-02

Downloads
19 (#1,172,631)

6 months
4 (#1,015,446)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Arthur L. Caplan
New York University

Citations of this work

Expanding the Ethical Analysis of Biobanks.Mark A. Rothstein - 2005 - Journal of Law, Medicine and Ethics 33 (1):89-101.
Genetic Exceptionalism and Legislative Pragmatism.Mark A. Rothstein - 2007 - Journal of Law, Medicine and Ethics 35 (S2):59-65.

Add more citations

References found in this work

No references found.

Add more references